Royalty Pharma plc Files 8-K for Operations Update
Ticker: RPRX · Form: 8-K · Filed: May 8, 2025 · CIK: 1802768
| Field | Detail |
|---|---|
| Company | Royalty Pharma PLC (RPRX) |
| Form Type | 8-K |
| Filed Date | May 8, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, financial-reporting, operations
TL;DR
Royalty Pharma filed an 8-K on May 8th, standard ops and financials update.
AI Summary
Royalty Pharma plc filed an 8-K on May 8, 2025, reporting on its Results of Operations and Financial Condition, and filing Financial Statements and Exhibits. The filing does not contain specific financial figures or operational details within the provided text, but indicates a standard reporting event.
Why It Matters
This filing serves as a public notification of significant corporate events or financial updates for Royalty Pharma plc, allowing investors and the market to stay informed.
Risk Assessment
Risk Level: low — This is a routine 8-K filing for reporting operational and financial information, not indicating any specific negative events.
Key Players & Entities
- Royalty Pharma plc (company) — Registrant
- May 8, 2025 (date) — Date of Report
- 110 East 59th Street (address) — Principal Executive Offices
- New York, New York (location) — Principal Executive Offices City and State
- 10022 (zip_code) — Principal Executive Offices Zip Code
- (212) 883-0200 (phone_number) — Registrant's telephone number
FAQ
What specific financial information is being reported in this 8-K?
The provided text indicates the filing pertains to 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits', but does not detail specific financial figures.
When was this 8-K filing submitted?
The filing was submitted on May 8, 2025.
What is the principal executive office address for Royalty Pharma plc?
The principal executive office is located at 110 East 59th Street, New York, New York, 10022.
What is the company's telephone number?
The company's telephone number is (212) 883-0200.
What is the SIC code for Royalty Pharma plc?
The Standard Industrial Classification (SIC) code for Royalty Pharma plc is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 8, 2025 regarding Royalty Pharma plc (RPRX).